Wednesday - September 11, 2024 - 08:50

Welcome Address & Chairperson’s opening remarks

Begin your conference journey with a warm welcome from our esteemed Chairperson

Wednesday - September 11, 2024 - 14:15

Panel Discussion - Integrated Drug Safety Surveillance Systems: Fostering Collaboration for Enhanced Pharmacovigilance

• Assessing the benefits and hurdles in forming a network that includes pharmaceutical companies, healthcare providers, and regulatory bodies for improved drug safety monitoring
• Discussing strategies for standardizing data collection, reporting, and analysis across various organizations to ensure consistent and reliable pharmacovigilance
• Investigating how AI, blockchain, and big data are transforming ADR detection and analysis, increasing the efficiency and precision of pharmacovigilance
• Emphasizing the need for effective communication and collaboration among patients, healthcare providers, and regulatory bodies to establish a trust-based pharmacovigilance system
• Detailing best practices and essential factors for successful collaborative pharmacovigilance, with a focus on regulatory compliance, data privacy, and cross-sector cooperation

Patient Safety Safety Signals & Management Data management & Analytics

Wednesday - September 11, 2024 - 17:35

Chairperson's Closing remarks

End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.

Thursday - September 12, 2024 - 08:50

Welcome Address & Chairperson’s opening remarks

Start the second day with insightful remarks from our Chairperson

Thursday - September 12, 2024 - 15:00

Navigating the digital fog: A case for intelligent automation in drug safety

AI & Automation Patient Centric Drug Safety

Thursday - September 12, 2024 - 15:50

Panel Discussion – Unleashing the Potential: Digital Transformation in Pharmacovigilance – Opportunities, Challenges and Future Directions

• How artificial intelligence and machine learning are reshaping pharmacovigilance by enhancing signal detection, automating adverse event processing, and predicting potential risks.
• The utilization of real-world data from sources such as electronic health records, social media, and wearables for more comprehensive and timely adverse event monitoring.
• The role of digital technologies in improving patient engagement and reporting of adverse events, and the impact of patient-generated data on pharmacovigilance efforts.
• Addressing the challenges related to data privacy, security, and compliance with evolving regulations in the context of digital transformation in pharmacovigilance.
• The emerging trends, opportunities, and best practices in the ongoing digital transformation journey within the field of pharmacovigilance.

AI & Automation Data management & Analytics

Thursday - September 12, 2024 - 18:00

Chairperson’s Closing Remarks

End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.